Literature DB >> 2499096

Malignant lymphomas of the nasal cavity and paranasal sinuses.

C Fellbaum1, M L Hansmann, K Lennert.   

Abstract

The incidence of malignant lymphomas in the nasal cavity and paranasal sinuses was found to be 0.17% of all malignant lymphomas and 0.44% of all extranodal malignant lymphomas registered in the Kiel Lymph Node Registry from 1972 to 1987. Fifty-nine cases of malignant lymphoma presenting in the nasal cavity and paranasal sinuses were investigated with morphological and immunological methods. The median age of the patients was 64.5 years, with a female predominance (m:f = 0.87:1). In the 59 cases a marked preponderance of B-cell lymphomas was found (centroblastic n = 15, immunoblastic n = 8, Burkitt's lymphoma n = 6, Immunocytoma n = 3, centrocytic n = 1, centroblastic/centrocytic n = 1, plasmacytic n = 11); only a small number (n = 5) was of T-cell lineage (pleomorphic types). Nine further cases could not be assigned with certainty to either the T or B cell system. Angiocentricity with infiltration and destruction of vessel walls by tumour cells was demonstrated only in the T-cell lymphomas; the B-cell lymphomas, in contrast, often surrounded and compressed blood vessels with intact endothelium. No similarity to malignant lymphomas of mucosa associated lymphoid tissue, such as those in the gastrointestinal tract, was detected.

Entities:  

Mesh:

Year:  1989        PMID: 2499096     DOI: 10.1007/bf00718623

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  37 in total

1.  Nasal T-cell lymphoma associated with hemophagocytic syndrome.

Authors:  C S Ng; J K Chan; P N Cheng; S C Szeto
Journal:  Cancer       Date:  1986-07-01       Impact factor: 6.860

2.  Which antibodies for diagnostic pathology?

Authors:  K C Gatter; D Y Mason; E Heyderman; P G Isaacson
Journal:  Histopathology       Date:  1987-06       Impact factor: 5.087

3.  Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma.

Authors:  S M Lippman; T M Grogan; C M Spier; C F Koopmann; E P Gall; D S Shimm; B G Durie
Journal:  Cancer       Date:  1987-03-01       Impact factor: 6.860

4.  The demonstration of B-cell, T-cell and myeloid antigens in paraffin sections.

Authors:  K P West; A Warford; L Fray; M Allen; A C Campbell; I Lauder
Journal:  J Pathol       Date:  1986-10       Impact factor: 7.996

5.  Midline granuloma syndrome: a clinicopathologic study of 13 patients.

Authors:  J D Crissman; M A Weiss; J Gluckman
Journal:  Am J Surg Pathol       Date:  1982-06       Impact factor: 6.394

6.  Extranodal non-Hodgkin's lymphoma.

Authors:  S Reddy; E Pellettiere; V Saxena; F R Hendrickson
Journal:  Cancer       Date:  1980-11-01       Impact factor: 6.860

7.  Occurrence and prognosis of extranodal lymphomas.

Authors:  C Freeman; J W Berg; S J Cutler
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

8.  Nonepithelial tumors of the nasal cavity, paranasal sinuses and nasopharynx: a clinicopathologic study. X. Malignant lymphomas.

Authors:  Y S Fu; K H Perzin
Journal:  Cancer       Date:  1979-02       Impact factor: 6.860

9.  Malignant lymphoma of mucosa-associated lymphoid tissue.

Authors:  P G Isaacson; J Spencer
Journal:  Histopathology       Date:  1987-05       Impact factor: 5.087

10.  Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms.

Authors:  J K Chan; C S Ng; W H Lau; S T Lo
Journal:  Am J Surg Pathol       Date:  1987-06       Impact factor: 6.394

View more
  18 in total

Review 1.  Hematolymphoid lesions of the sinonasal tract.

Authors:  Genevieve M Crane; Amy S Duffield
Journal:  Semin Diagn Pathol       Date:  2015-09-09       Impact factor: 3.464

2.  Isolated skeletal muscle recurrence of the paranasal sinus lymphoma in complete remission.

Authors:  Hakan Karagol; Duygu Derin; Mert Basaran; Sevil Bavbek
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

3.  Large cell anaplastic lymphoma: evaluation of immunophenotype on paraffin and frozen sections in comparison with ultrastructural features.

Authors:  M L Hansmann; C Fellbaum; A Bohm
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  MALT lymphoma of the paranasal sinuses and the hard palate: report of two cases and review of the literature.

Authors:  Stefan Tauber; Andreas Nerlich; Stephan Lang
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-12-01       Impact factor: 2.503

5.  Immunohistochemical differential diagnosis of granulocytic sarcomas and malignant lymphomas on formalin-fixed material.

Authors:  C Fellbaum; M L Hansmann
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

6.  Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival.

Authors:  C Jenkins; G E Rose; C Bunce; J E Wright; I A Cree; N Plowman; S Lightman; I Moseley; A Norton
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

7.  Clinical findings of extranodal SNT lymphoid malignancies in a four-decade single-centre series.

Authors:  Pauli Vähämurto; Kaija Silventoinen; Seija I Vento; Marja-Liisa Karjalainen-Lindsberg; Aaro Haapaniemi; Leif Bäck; Susanna Mannisto; Sirpa Leppä; Antti A Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-24       Impact factor: 2.503

8.  Clinical analysis of extranodal non-Hodgkin's lymphoma in the sinonasal tract.

Authors:  J-S Woo; J M Kim; S H Lee; S W Chae; S J Hwang; H-M Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-07-25       Impact factor: 2.503

9.  Sinonasal non-Hodgkin's lymphomas and Wegener's granulomatosis: a clinicopathological study.

Authors:  L A Noorduyn; R Torenbeek; P van der Valk; P B Drosten; G B Snow; A J Balm; G J Ossenkoppele; C J Meyer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

10.  Primary B cell lymphoma of paranasal sinuses: a diagnostic surprise.

Authors:  T S Anand; Y K Saxena; T B Shashidhar; Soumitra Kumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2008-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.